-
HA380 hemoperfusion cartridge-- Essential treatmen...2023-02-20 -
Golden Bull Award! Jafron Wins Golden Bull Award ...2023-02-08 -
Expert Consensus on Artificial Liver Therapy2023-01-18 -
Mr. Jean Paul Menneguerre, Senior Head of the EMEA...2023-01-12 -
Jafron in Jordan: Facilitator of the Local Healthc...2023-01-11 -
ESICM: Getting to Know Jafron from Different Persp...2023-01-11 -
HA230 Applied in a Patient Suffering from Severe D...2023-01-11 -
Jafron Q3 Report 2022: Prepping for the Winter2023-01-11 -
Jafron：Master the acute phase2023-01-11
-
HA380 hemoperfusion cartridge-- Essential treatments for critical illness2023-02-20
-
Golden Bull Award! Jafron Wins Golden Bull Award for Highest Investment Value o...2023-02-08
-
Expert Consensus on Artificial Liver Therapy2023-01-18
-
Mr. Jean Paul Menneguerre, Senior Head of the EMEA markets of Jafron Biomedical ...2023-01-12
-
Jafron in Jordan: Facilitator of the Local Healthcare Industry2023-01-11
-
ESICM: Getting to Know Jafron from Different Perspectives2023-01-11
-
HA230 Applied in a Patient Suffering from Severe Deltamethrin Poisoning2023-01-11
-
Jafron Q3 Report 2022: Prepping for the Winter2023-01-11
-
Jafron：Master the acute phase2023-01-11
Jafron Biomedical Co., Ltd.
Address : No. 98 Technology Six Road, High-tech Zone, Zhuhai City, China
E-mail : customerservice@jafron.com
Website : https://www.jafroninternational.com
Terms of Use｜Site Map｜ Cookie Notice｜ Privacy Notice
Recruitment Privacy Notice｜ 7/24 Hotline
© 2016 Jafron Biomedical Co., Ltd. All rights reserved.
